Baseline differences in the SAVOR trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1463-1326|17|12|1202-1202

ISSN： 1462-8902

Source： DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.17, Iss.12, 2015-12, pp. : 1202-1202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Response to: ‘baseline differences in SAVOR trial’ – prespecified vs. post hoc analysis – a potential source of bias

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 12, 2015-12 ,pp. : 1203-1204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 4, 2015-04 ,pp. : 395-402

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 10, 2015-10 ,pp. : 1075-1083

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heart failure in SAVOR‐TIMI 53: The hindsight of diabetic retinopathySAVOR‐TIMI 53研究中的心脏衰竭：糖尿病视网膜病变的后尘

By  

JOURNAL OF DIABETES, Vol. 7, Iss. 3, 2015-05 ,pp. : 304-306

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized intervention trial on preventive home visits to older people: Baseline and follow-up characteristics of participants and non-participants

By Vass Mikkel  

Scandinavian Journal of Public Health, Vol. 35, Iss. 4, 2007-01 ,pp. : 410-417

Informa Healthcare

Access to resources Recommend Favorite